Quick Answer
Silo Pharma, Inc. reported Total Revenue of $72.1 thousand for the year ending 2025.
- Silo Pharma, Inc. showed an increase of +0.0% in Total Revenue from 2024 to 2025.
- This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $268.00 | Q1 2020: $294.00 | Q2 2020: $2.2 thousand | Q3 2020: $16.3 thousand | Q1 2021: $47.4 thousand | Q2 2021: $68.1 thousand | Q2 2022: $18.0 thousand | Q3 2022: $18.0 thousand | Q1 2023: $18.0 thousand | Q2 2023: $18.0 thousand | Q3 2023: $18.0 thousand | Q1 2024: $18.0 thousand | Q2 2024: $18.0 thousand | Q3 2024: $18.0 thousand | Q1 2025: $18.0 thousand | Q2 2025: $18.0 thousand | Q3 2025: $18.0 thousand.
- Over the full 6 years of available data (2019 to 2025), Silo Pharma, Inc.'s Total Revenue has grown by 77.7%.
- Historical annual values: Fiscal year 2025: $72.1 thousand | Fiscal year 2024: $72.1 thousand | Fiscal year 2023: $72.1 thousand | Fiscal year 2022: $72.1 thousand | Fiscal year 2020: $40.9 thousand | Fiscal year 2019: $40.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: